(Q45930474)

English

Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts.

scientific article published on 20 January 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23335199

Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23335199

0 references

Veronique Avettand-Fenoel

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23335199

Christine Rouzioux

11

object named as

Christine Rouzioux

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

author name string

Laurent Hocqueloux

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23335199

Sophie Jacquot

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23335199

Thierry Prazuck

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23335199

Eric Legac

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23335199

Adeline Mélard

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23335199

Mohamadou Niang

7

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23335199

Catherine Mille

8

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23335199

Gwenaël Le Moal

9

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23335199

Jean-Paul Viard

10

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23335199

AC32 (Coordinated Action on HIV Reservoirs) of the Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ANRS)

12

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23335199

language of work or name

0 references

publication date

20 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23335199

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23335199

68

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23335199

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23335199

1169-1178

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23335199

Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Impact of inversion of the CD4/CD8 ratio on the natural history of HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Relationship between the size of the human immunodeficiency virus type 1 (HIV-1) reservoir in peripheral blood CD4+ T cells and CD4+:CD8+ T cell ratios in aviremic HIV-1-infected individuals receiving long-term highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Cellular HIV-1 DNA load predicts HIV-RNA rebound and the outcome of highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudine

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

HIV cure and eradication: how will we get from the laboratory to effective clinical trials?

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Cellular HIV-1 DNA quantification and short-term and long-term response to antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Proviral HIV-DNA predicts viral rebound and viral setpoint after structured treatment interruptions

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadir

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Immune and viral correlates of "secondary viral control" after treatment interruption in chronically HIV-1 infected patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Effect of early versus deferred antiretroviral therapy for HIV on survival

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1 seroconverters

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Clinical management of acute HIV infection: best practice remains unknown

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Profound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infection

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressors

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

LTR real-time PCR for HIV-1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01).

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective cohort

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Elite controllers as a model of functional cure

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Despite being highly diverse, immunovirological status strongly correlates with clinical symptoms during primary HIV-1 infection: a cross-sectional study based on 674 patients enrolled in the ANRS CO 06 PRIMO cohort

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Prevention of HIV-1 infection with early antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Mixed-Effects Models in Sand S-PLUS

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS533

21 January 2018

Identifiers

10.1093/JAC/DKS533

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23335199

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23335199

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45930474&oldid=1425548562"